Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Viral Vector Production Market, by Type
1.4.2 Asia Pacific Viral Vector Production Market, by Indication
1.4.3 Asia Pacific Viral Vector Production Market, by Application
1.4.4 Asia Pacific Viral Vector Production Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis
Chapter 4. Strategies Deployed in Viral Vector Production Market
Chapter 5. Asia Pacific Viral Vector Production Market, by Type
5.1 Asia Pacific Adeno-Associated Viral Vectors Market, by Country
5.2 Asia Pacific Lentiviral Vectors Market, by Country
5.3 Asia Pacific Adenoviral Vectors Market, by Country
5.4 Asia Pacific Retroviral Vectors Market, by Country
5.5 Asia Pacific Others Market, by Country
Chapter 6. Asia Pacific Viral Vector Production Market, by Indication
6.1 Asia Pacific Cancer Market, by Country
6.2 Asia Pacific Genetic Disorders Market, by Country
6.3 Asia Pacific Infectious Diseases Market, by Country
6.4 Asia Pacific Others Market, by Country
Chapter 7. Asia Pacific Viral Vector Production Market, by Application
7.1 Asia Pacific Gene Therapy Market, by Country
7.2 Asia Pacific Vaccinology Market, by Country
Chapter 8. Asia Pacific Viral Vector Production Market, by Country
8.1 China Viral Vector Production Market
8.1.1 China Viral Vector Production Market, by Type
8.1.2 China Viral Vector Production Market, by Indication
8.1.3 China Viral Vector Production Market, by Application
8.2 Japan Viral Vector Production Market
8.2.1 Japan Viral Vector Production Market, by Type
8.2.2 Japan Viral Vector Production Market, by Indication
8.2.3 Japan Viral Vector Production Market, by Application
8.3 India Viral Vector Production Market
8.3.1 India Viral Vector Production Market, by Type
8.3.2 India Viral Vector Production Market, by Indication
8.3.3 India Viral Vector Production Market, by Application
8.4 South Korea Viral Vector Production Market
8.4.1 South Korea Viral Vector Production Market, by Type
8.4.2 South Korea Viral Vector Production Market, by Indication
8.4.3 South Korea Viral Vector Production Market, by Application
8.5 Singapore Viral Vector Production Market
8.5.1 Singapore Viral Vector Production Market, by Type
8.5.2 Singapore Viral Vector Production Market, by Indication
8.5.3 Singapore Viral Vector Production Market, by Application
8.6 Malaysia Viral Vector Production Market
8.6.1 Malaysia Viral Vector Production Market, by Type
8.6.2 Malaysia Viral Vector Production Market, by Indication
8.6.3 Malaysia Viral Vector Production Market, by Application
8.7 Rest of Asia Pacific Viral Vector Production Market
8.7.1 Rest of Asia Pacific Viral Vector Production Market, by Type
8.7.2 Rest of Asia Pacific Viral Vector Production Market, by Indication
8.7.3 Rest of Asia Pacific Viral Vector Production Market, by Application
Chapter 9. Company Profiles
9.1 Andelyn Biosciences, Inc.
9.1.1 Company Overview
9.1.2 Recent strategies and developments:
9.1.2.1 Partnerships, Collaborations, and Agreements:
9.1.2.2 Geographical Expansions:
9.2 Charles River Laboratories International, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Recent strategies and developments:
9.2.4.1 Product Launches and Product Expansions:
9.2.4.2 Acquisition and Mergers:
9.2.4.3 Geographical Expansions:
9.2.5 SWOT Analysis
9.3 Danaher Corporation
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 SWOT Analysis
9.4 FinVector Oy (Ferring Ventures S/A)
9.4.1 Company Overview
9.5 Thermo Fisher Scientific, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Acquisition and Mergers:
9.5.5.2 Geographical Expansions:
9.5.6 SWOT Analysis
9.6 Novartis AG
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 SWOT Analysis
9.7 Takara Bio Inc. (Takara Holdings Inc.)
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.8 Avid Bioservices, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Recent strategies and developments:
9.8.3.1 Geographical Expansions:
9.9 Oxford Biomedica plc
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expenses
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.5.2 Product Launches and Product Expansions:
9.10. Lonza Group Ltd.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 SWOT Analysis
Unique Offerings 